🔗 Share this article

An underground economy for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on new investigations.

Investigational Drug Acquiring Popularity Online

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these accounts privately for supplier links, while also receiving discount codes.

Thriving Commerce on Messaging Platforms

Separately, a flourishing trade exists on Telegram, where groups with thousands of participants share comparison photos, injection guides and claims of next-day British shipping. Vendors market the drug there before redirecting customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injection developed by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Experts Express Worries

However, physicians and chemists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could result in individuals injecting substances of unknown origin.

Some professionals said the popularity for the experimental drug could be connected to the increasing cost of approved slimming products such as Mounjaro.

Regulatory Position and Implementation

Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the British medical regulations.

Some influencers attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate medicines, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Content Elimination

Based on the social media company, the platform has taken down violative content and prohibited associated keywords and search suggestions. The organization said it was dedicated to maintaining the platform safe and allocating resources in enhancing enforcement strategies.

Digital Marketplace Activities

Investigations also found communities with up to nine thousand members selling retatrutide using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately displays channels with thousands of users, filled with photos of slimming results, glowing reviews and step-by-step guides for preparing or administering at residence.

After moments of joining one group, a vendor shared WhatsApp details, where most purchases take place. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one asked about weight, health issues or previous experience.

Item Details and Costs

Inside these communities, posts display black plastic packages with postal service stickers, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically priced at £160 for 20mg. When asked how much time a injector should last, sellers give conflicting answers varying between a several days to “depends on your body”.

Service Moderation and Security Measures

A representative for Telegram stated it regularly monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting materials they cannot confirm. Even if the science behind this drug is sound, these online products may not contain what they claim,” said a pharmacy expert, the head of pharmaceutical services at a pharmacy service.

A medical professional of an online medical service connected the increase in demand to recent price rises for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her team has already seen individuals harmed by self-injection from unverified suppliers. “We recognize the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or approved by any government authority globally. “Consequently at this time no one can sell [it] for human use,” they explained, noting that any product “falsely representing itself as a company investigational substance not yet approved … may subject users to possibly significant health risks”.